[Federal Register Volume 63, Number 197 (Tuesday, October 13, 1998)]
[Notices]
[Page 54722]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-27381]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Sickle Cell Disease Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: November 13, 1998.
Time: 9:00 AM to 5:00 PM.
Agenda: To discuss recommendations on the implementation and
evaluation of the NHLBI sickle cell disease program.
Place: National Institutes of Health, Two Rockledge Center,
Conference Room 9104, 6701 Rockledge Drive, Bethesda, MD 20892.
Contact Person: Elaine Sloand, MD, Acting Director, Division of
Blood Diseases and Resources, National Heart, Lung, and Blood
Institute, Two Rockledge Center, Suite 10160, 6701 Rockledge Drive,
Bethesda, MD 20892, (301/435-0080.
(Catalogue of Federal Domestic Assistance Program Nos. 93.839, Blood
Diseases and Resources Research, National Institutes of Health, HHS)
Dated: October 5, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-27381 Filed 10-9-98; 8:45 am]
BILLING CODE 4140-01-M
